Captrust Financial Advisors Assembly Biosciences, Inc. Transaction History

Captrust Financial Advisors

  • $30.9 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 16, 2021
SELL
$3.14 - $3.9 $508 - $631
-162 Closed
0 $0
Q2 2021

Aug 16, 2021
SELL
$3.8 - $4.56 $969 - $1,162
-255 Reduced 61.15%
162 $1,000
Q1 2021

May 17, 2021
BUY
$4.33 - $6.63 $1,805 - $2,764
417 New
417 $2,000

Others Institutions Holding ASMB

# of Institutions
1
Shares Held
16.3K
Call Options Held
0
Put Options Held
0
View Full List

About ASSEMBLY BIOSCIENCES, INC.

ASMB Quotes by TradingView
  • Ticker ASMB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,436,900
  • Market Cap $822M
  • Description
  • Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...
More about ASMB
Track This Portfolio

Track Captrust Financial Advisors Portfolio

Follow Captrust Financial Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email